ipilimumab
bms
['melanoma', 'ipilimumab']
treatment with tumor-infiltrating lymphocytes (til) versus ipilimumab for advanced melanoma: results from a multicenter, randomized phase iii trial
john haanen (nl) #esmo22 great talk!! 
Pt Adv, NCI Rectal Anal TF
Mom, lifelong learner
Wants to bring patient voice to research, clinical trials & more!
Check out @CRCTrialsChat
1st love: Virology